Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.40 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 3/20 | 0.40 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.40 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.40 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 3/20 | 0.38 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.38 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Phenylbenzo[D]Oxazole SCHEMBL9544026 | 0.81 | NPC1 (0.50) | ELANERAB9ANPC1POLBTP53 | |
| SCHEMBL5583818 | 0.71 | ELANE (0.54) | ELANERAB9AL3MBTL1NPC1NR1H2 | |
| SCHEMBL17831574 | 0.71 | MPO (0.42) | HSD17B10KDM4EGAAALDH1A1HPGD | |
| SCHEMBL5763004 | 0.68 | MPO (0.46) | L3MBTL1NPC1NR1H2NR1H3TP53 | |
| SCHEMBL8304178 | 0.68 | ELANE (0.54) | ELANERAB9AL3MBTL1NPC1POLB | |
| SCHEMBL27971365 | 0.68 | ELANE (0.54) | ELANERAB9AL3MBTL1NPC1NR1H2 | |
| SCHEMBL28283327 | 0.67 | MPO (0.60) | POLBKDM4EGAAALDH1A1HPGD | |
| SCHEMBL8143932 | 0.66 | NPC1 (0.44) | ELANERAB9AL3MBTL1NPC1NR1H2 | |
| SCHEMBL11752876 | 0.66 | TSHR (0.47) | ELANEL3MBTL1NPC1POLBHSD17B10 | |
| SCHEMBL4684902 | 0.66 | HDAC8 (0.44) | ELANERAB9AL3MBTL1NPC1PDGFRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1499 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3164196-B1 | TOPICAL FORMULATIONS FOR UV PROTECTION | TOPGENIX INC (US) | 2021-08-18 | — | — | EP | claimed |
| EP-3164196-A1 | TOPICAL FORMULATIONS FOR UV PROTECTION | TOPGENIX, INC. (US) | 2017-05-10 | — | — | EP | claimed |
| US-20170119641-A1 | TOPICAL FORMULATIONS FOR UV PROTECTION | TopGeniX, Inc. | 2017-05-04 | — | — | US | claimed |
| WO-2015195546-A1 | TOPICAL FORMULATIONS FOR UV PROTECTION | TopGeniX, Inc. (US) | 2015-12-23 | — | — | WO | claimed |
| EP-2916814-A1 | COMPOSITION CONTAINING A CELLULOSE DERIVED CAPSULE WITH A SUNSCREEN | Colabs International Corporation (US) | 2015-09-16 | — | — | EP | claimed |
| WO-2014074555-A1 | COMPOSITION CONTAINING A CELLULOSE DERIVED CAPSULE WITH A SUNSCREEN | CoLabs International Corporation (US) | 2014-05-15 | — | — | WO | claimed |
| US-20140127275-A1 | Composition Containing a Cellulose Derived Capsule With A Sunscreen | CoLabs International Corporation (US) | 2014-05-08 | — | — | US | claimed |
| CN-102245643-A | Cosmetic composition containing acetylated oligoglucuronans | SEDERMA SA | 2011-11-16 | — | — | CN | claimed |
| EP-2367852-A1 | COSMETIC COMPOSITION CONTAINING ACETYLATED OLIGOGLUCURONANS | Sederma (FR) | 2011-09-28 | — | — | EP | claimed |
| US-20110008272-A1 | Use of Creatine or Creatine Compounds for Skin Preservation | AVICENA GROUP, INC. (US) | 2011-01-13 | — | — | US | claimed |
| WO-2010067327-A1 | COSMETIC COMPOSITION CONTAINING ACETYLATED OLIGOGLUCURONANS | SEDERMA (FR) | 2010-06-17 | — | — | WO | claimed |
| WO-2010044076-A2 | COSMETIC AND TOPICAL USE OF XANTHOHUMOL INCLUDING BRIGHTENING SKIN COMPLEXION AND REDUCING CUTANEOUS REDNESS | SEDERMA (FR) | 2010-04-22 | — | — | WO | claimed |
| EP-1924254-A2 | USE OF TELLURIUM COMPOUNDS FOR PROTECTION FROM ULTRA-VIOLET RADIATION | Biomas Ltd. (IL) | 2008-05-28 | — | — | EP | claimed |
| WO-2007032010-A2 | USE OF TELLURIUM COMPOUNDS FOR PROTECTION FROM ULTRA-VIOLET RADIATION | BIOMAS LTD. (IL) | 2007-03-22 | — | — | WO | claimed |
| US-20060193789-A1 | Surfacant, film forming agent, water, gas propellant; plant and animal extracts and oils; may include malathion | FOAMIX LTD. (IL) | 2006-08-31 | — | — | US | claimed |
| US-20050186158-A1 | Use of creatine or creatine compounds for skin preservation | AVICENA GROUP, INC. (US) | 2005-08-25 | — | — | US | claimed |
| US-20260091073-A1 | COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME | CYDEX PHARMACEUTICALS INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-12589057-B2 | Cosmetic composition of liquid crystal lipid particles for personal care applications | BASF SE (DE) | 2026-03-31 | — | — | US | disclosed |
| US-4098881-A | COMPOSITIONS TO CONTROL THE CHRONIC EFFECTS OF EXPOSURE TO SUNLIGHT COMPRISING CONJUGATED DIENES | THE PROCTER & GAMBLE COMPANY (US) | 1978-07-04 | — | — | US | disclosed |
| US-4009254-A | UNSYMMETRICAL ETHERS; SUNSCREEN AGENTS | COLGATE-PALMOLIVE COMPANY (US) | 1977-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110008272-A1 | Use of Creatine or Creatine Compounds for Skin Preservation | PC, CKMT1A; CKMT1B, CHEK1 | ELANE 2895/4885RAB9A 3608/4885L3MBTL1 3145/4885 |
| US-20140127275-A1 | Composition Containing a Cellulose Derived Capsule With A Sunscreen | MSH6, TYR, CUTA | ELANE 1317/4885RAB9A 3568/4885L3MBTL1 4831/4885 |
| US-20170119641-A1 | TOPICAL FORMULATIONS FOR UV PROTECTION | ERCC4, ERCC1, UNG | ELANE 395/4885RAB9A 1217/4885L3MBTL1 4347/4885 |
| US-12589057-B2 | Cosmetic composition of liquid crystal lipid particles for personal care applications | DSG1, H1-10, DSC1 | ELANE 232/4885RAB9A 355/4885L3MBTL1 1524/4885 |
| US-20050186158-A1 | Use of creatine or creatine compounds for skin preservation | PC, CKMT1A; CKMT1B, CHEK1 | ELANE 2895/4885RAB9A 3608/4885L3MBTL1 3145/4885 |
| US-20260091073-A1 | COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME | GYS2, COL1A1, COL14A1 | ELANE 2543/4885RAB9A 1189/4885L3MBTL1 1705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.